Zhong Nanshan

Chinese pulmonologist

In this Chinese name, the family name is  Zhong.

Not to be confused with Zhongnan Mountains.

Professor

Zhong Nanshan

FRCPE FRCP FRCPI

钟南山

Zhong in 2015

Delegate to the National People's Congress
(11th, 12th)
In office
March 2008 – March 2018
Chairman| Wu Bangguo→Zhang Dejiang
Member of the National Committee of the Chinese People's Political Consultative Conference
(8th, 9th, 10th)
In office
March 1993 – March 2008
Chairman| Li Ruihuan→Jia Qinglin
Delegate to the National Congress of the Chinese Communist Party
(17th)
In office
1997–2002
General Secretary| Hu Jintao
Personal details
Born|  (1936-10-20) 20 October 1936 (age 87)
Nanjing, Jiangsu, China
Political party| Chinese Communist Party
Spouse|

Li Shaofen [zh]

(m. 1963)​

Children| 3
Alma mater| Peking University Health Science Center
University of Edinburgh Medical School
Occupation| pulmonologist
Awards| Medal of the Republic (2020)
Known for| Discovering the SARS coronavirus
Scientific career
Fields| Pulmonology, respiratory diseases
Institutions| Guangzhou Institute of Respiratory Diseases
Guangzhou Medical University
Chinese name
Simplified Chinese| 钟南山
Traditional Chinese| 鍾南山
Literal meaning| Zhong South-mountain
| Transcriptions

Standard Mandarin
Hanyu Pinyin| Zhōng Nánshān
IPA| [ʈʂʊ́ŋ nǎnʂán]
Yue: Cantonese
Yale Romanization| Jūng Nàahm-sāan
Jyutping| Zung1 Naam4-saan1
IPA| [tsoŋ˥ naːm˩saːn˥]
Southern Min
Hokkien POJ| Cheng Lâm-soaⁿ

Zhong Nanshan FRCPE FRCP FRCPI (born 20 October 1936)[1] is a Chinese pulmonologist.[2] He was president of the Chinese Medical Association from 2005 to 2009 and is currently the editor-in-chief of the Journal of Thoracic Disease.[2] He is a recipient of Medal of the Republic, the highest honour of China.

Zhong earned international fame for managing the SARS outbreak[3] and was renowned for refuting the official line which downplayed the severity of the crisis.[4] He was voted one of China's top 10 scientists in 2010.[5]

During the COVID-19 pandemic which was first identified in Wuhan, Hubei, Zhong was a leading advisor in managing the crisis, suggesting evidence-based control measures to contain the disease and sharing the successful treatment plan with the international community.[4][6] He was named by Time as one of the 100 most influential people in the world in 2020.[6]

## Early life and education[edit]

Zhong was born on 20 October 1936 at the Central Hospital in Nanjing，Because the hospital is located south of Zhongshan in Nanjing, his parents named it "Nanshan" according to the location of his birthplace.,[1][7] though his family was from Fujian province.[8] He was educated at Beijing Medical University, where he finished his residency training in internal medicine. After graduating from university in 1960, Zhong Nanshan had few opportunities to participate in clinical medicine. He once taught medicine, worked as a worker, and edited the school newspaper until he was transferred back to the Affiliated Hospital of Guangzhou Medical College in 1971. Zhong completed further training at St Bartholomew's Hospital in London and the University of Edinburgh Medical School between 1979 and 1981, graduating from the University of Edinburgh Medical School with an MD in 1981.[2]

## Career[edit]

Zhong Nanshan was awarded the title of one of the first batch of national-level experts with outstanding contributions in 1984. Served as graduate tutor in 1985.In 1995, he became a doctoral supervisor. In May 1996, he was elected as an academician of the Chinese Academy of Engineering.Zhong became president of the Chinese Thoracic Society in 2000 and became president of the Chinese Medical Association in 2005. He is currently the director of the Guangzhou Institute of Respiratory Diseases and editor-in-chief of the Journal of Thoracic Disease.[2] Zhong discovered the relationship between protein malnutrition and COPD and has developed a calibrated formula on energy consumption for patients with COPD.[7]

### SARS outbreak[edit]

See also: 2002–2004 SARS outbreak

This article needs more reliable medical references for verification or relies too heavily on primary sources. Please review the contents of the article and add the appropriate references if you can. Unsourced or poorly sourced material may be challenged and removed. Find sources: "Zhong Nanshan" – news · newspapers · books · scholar · JSTOR (March 2020)

|
|

This section of a biography of a living person needs additional citations for verification. Please help by adding reliable sources. Contentious material about living persons that is unsourced or poorly sourced must be removed immediately from the article and its talk page, especially if potentially libelous.
Find sources: "Zhong Nanshan" – news · newspapers · books · scholar · JSTOR (March 2020) (Learn how and when to remove this template message)

|

When Zhong directed the Guangzhou Institute of Respiratory Diseases, they received the second case of a SARS patient as early as 20 December 2002. Over the next month, 28 similar cases were reported in Zhongshan alone, and on 21 January 2003, Zhong and other doctors and researchers in related fields reported this disease at an emergency meeting and gave it the name atypical pneumonia.[9]

On 28 January 2003, Zhong felt sick and discovered that he had caught pneumonia. Concerned that the news that a leading researcher and doctor for respiratory diseases falling ill during the SARS outbreak would cause fear and panic for the general public, Zhong decided to not receive treatment in the hospital.[citation needed] Instead he returned home, hoping that it was not caused by SARS and that he could recover without treatment. With care from his wife, Li Shaofen, he managed to recover after eight days. After recovery he immediately returned to the Guangzhou Institute of Respiratory Diseases to direct the fight against SARS. On 11 February 2003, at a press conference held by the Guangdong Department of Health, Zhong explained the disease and its symptoms, and calmed the public by asserting that it was "preventable" and "curable".[9]

Zhong, for the first time while treating SARS patients, employed non-invasive ventilation methods that increased the amount of oxygen that the patients could take in and alleviated pain. Zhong also insisted on proposing the use of cortisone for the treating of patients experiencing severe conditions, which significantly lowered the death rate of severe patients to 13% and decreased the total treatment time.[citation needed]

The decision to use cortisone was politically controversial at the time. In February 2003 the Chinese Center for Disease Control and Prevention had already published the authoritative view that normal Chlamydia was the direct cause of atypical pneumonia and, as a result, the only legally prescribed way of treating SARS patients was to use antibiotics. Based on observations of hundreds of patients in Guangdong, Zhong was determined to advocate for the moderate usage of cortisone. Zhong said later in an interview that he knew this might bring dishonor and defamation, but he persisted because he trusted in his observations and scientific judgements regarding the disease.[9]

With the support of the Guangdong government and the positive results in Guangdong in the treating of SARS disease, Zhong's method was later used as the standard protocol for treating all SARS patients in China.[9]

When delegates led by Dr. Evans from the World Health Organization visited China in early April, Zhong presented the characteristics of SARS as well as the treatment and prevention method in China. Zhong's presentation was well-received and his methods were adopted around the world.[9]

### COVID-19[edit]

In early January 2020, Zhong visited Wuhan, in response to a growing cluster of then-unidentified pneumonia cases, and was reassured by city health officials that the disease was controllable and preventable. On 20 January, however, he returned to Wuhan, to re-evaluate the situation, and came to the conclusion that the novel coronavirus was more transmissible than previously identified, and warned the Central Committee of the Chinese Communist Party[10] that authorities in Wuhan were likely understating the severity of the outbreak, and on the same day, publicly announced on state television the same.[10] In later reporting of his state TV broadcast he recommended that "a quarantine period of 10 days to two weeks is very effective, so there will not be a large-scale infection as people travel back from their holidays" but also concluded with the prediction that "the virus outbreak may recede in a week to 10 days."

Zhong has compiled a coronavirus diagnosis and treatment protocol, and has made great contributions to the prevention and control of epidemics, treatment of severe cases, and COVID-19 research. In August 2020, he received from Chinese leader Xi Jinping the Medal of the Republic, the highest state honor, for his outstanding contribution to fighting the COVID-19 epidemic.[11]

On 12 December 2020, the Affiliated High School of South China Normal University held its 132nd anniversary, a bronze statue of Zhong Nanshan was unveiled by himself.[12]

During the pandemic, Zhong had promoted publicly[13] the usage of a controversial [14] traditional Chinese medicine of Lianhua Qingwen capsule for treating Covid-19 infection. Though later he had denied any commercial tie with the pharmatheutical company that supplies the capsule,[15] on 4 May 2021, an article from Retraction Watch[16] showed that Zhong and his coworkers were financially tied to the Yiling Pharmaceutical company that supplies the capsule.

## Honors[edit]

Awards and Prizes

* 2020: Order of the Republic[17]
* 2016: Guanghua Engineering Science and Technology Prize[18]
* National Award for Advances in Science and Technology, China (1997)[19]
* National Role Model of Labors (2005)[19]
* WAO Awards for Distinguished Recognition (2007)[19]

Paper of the Year

* The Lancet; 2008: The editorial board praised Zhong and his team, as they "clarified that carbocisteine can prevent the worsening of chronic obstructive pulmonary disease and can improve life at an affordable price, which is of great significance to developing countries." (Note: The editorial board selected six papers for readers to vote, and announced two winners, one selected by the editorial board and one with the highest reader votes. Zhong's paper obtained the highest number of votes.)[20][21]

Professional Titles

* 1989: Fellow of the American College of Chest Physicians[19]
* 1993: Member of the European Respiratory Society[19]
* 2005: Fellow of the Royal College of Physicians of Ireland[19]
* 2011: Fellow of the Royal College of Physicians of Edinburgh[19]
* 201?: Fellow of the Royal College of Physicians of London[22]

Honorary Degrees

* 2005: Honorary Fellow of Hong Kong Academy of Medicine[19]
* 2008: Honorary Fellow of the European Respiratory Society[19]
* 2007: Doctor of Medicine (Honors), University of Edinburgh[23]
* 2011: Honorary Doctor of Science, University of Birmingham
* 2013: Honorary Doctor of Science, The Chinese University of Hong Kong[24]

Professional Societies

* 1985–1990: Member, WHO Advisory Panel on Smoking & Health[19]
* 1982–1985: Member, Executive Committee, Chinese Medical Association[19]
* 1989–2000: Member, Executive Committee, American College of Chest Physicians[19]
* 1989–present: Fellow, American College of Chest Physicians (FCCP)[19]

## Personal life[edit]

Zhong Nanshan and Li Shaofen in 1963

Zhong was an outstanding college athlete in the 1950s. The Beijing Municipal Track and Field Team attempted to recruit him as a full-time athlete, but he was determined to become a doctor and declined the offer. Through his sports connection, he was introduced to Li Shaofen [zh], a basketball player who was a member of the China women's national basketball team for 13 years. And won the 1964 French "Four Nations" women's basketball championship. But because Li Shaofen was a member of the national women's basketball team at the time and could not get married, Zhong Nanshan waited for her for eight years. They married on 31 December 1963.[25] They have two children: son Zhong Weide, a physician,he is a doctor in the Urology Department of Guangzhou First People's Hospital and the absolute main force of the hospital's basketball team,and daughter Zhong Weiyue, a swimmer, once won the short course world championship.[26]His father, Zhong Shifan, is a doctor of medicine from the State University of New York and a pediatric medical expert. His mother, Liao Yueqin, graduated from Peking Union Medical College and is the founder of Guangdong Cancer Hospital.

## See also[edit]

* Carlo Urbani, doctor who was the first to identify SARS and died of the disease in 2003
* Chen Wei, medical researcher who won multiple national awards
* Li Lanjuan, medical researcher who won multiple national awards

## References[edit]

1. ^ a b 钟南山 (in Chinese (China)). Chinese Academy of Engineering. Archived from the original on 23 June 2016. Retrieved 18 February 2016.
2. ^ a b c d "Editor-in-Chief: Prof. Dr. Zhong Nanshan, MD". Journal of Thoracic Disease. Archived from the original on 17 July 2013. Retrieved 18 July 2013.
3. ^ "SARS hero Zhong Nanshan named China's best scientist". whatsonxiamen. Archived from the original on 3 February 2015. Retrieved 18 July 2013.
4. ^ a b "The coronavirus discovered in China is causing global alarm". The Economist. 23 January 2020. ISSN 0013-0613. Archived from the original on 26 January 2020. Retrieved 29 January 2020.
5. ^ "SARS hero named among China's 10 best scientists, technicians". Xinhua. Archived from the original on 20 December 2010. Retrieved 20 July 2013.
6. ^ a b "Zhong Nanshan: The 100 Most Influential People of 2020". Time. Retrieved 23 September 2020.
7. ^ a b "Zhong Nanshan". The HoLeung Ho Lee Foundation. Archived from the original on 6 June 2014. Retrieved 20 July 2013.
8. ^ 院士钟南山回乡传授长寿秘诀. www.taihainet.com (in Chinese (China)). Archived from the original on 25 January 2020. Retrieved 21 January 2020.
9. ^ a b c d e Ye 叶, Yi 依 (2010). 钟南山传. Beijing: 作家出版社. pp. 49–52. ISBN 978-7-5063-5267-3.
10. ^ a b "Meet Dr. Zhong Nanshan, The Public Face Of The COVID-19 Fight In China". NPR.org.
11. ^ Liu, Jie. "Zhong Nanshan: outspoken doctor awarded China's top honor".
12. ^ 为自己塑像揭幕惊诧众人 钟南山人设遭遇两极分化. 163.com (in Chinese). 16 December 2020. Retrieved 22 December 2020.
13. ^ "钟南山：有充足证据证明连花清瘟对新冠肺炎有效". www.cdctj.com.cn. Retrieved 28 May 2021.
14. ^ 观察者网 (8 May 2020). "中国推荐有效药，瑞典：成分只是薄荷醇，禁止进口". finance.sina.com.cn. Retrieved 28 May 2021.
15. ^ "钟南山否认商业代言传闻：我怎么会做那些东西 | 每经网". www.nbd.com.cn. Retrieved 28 May 2021.
16. ^ "Prominent Chinese scientist failed to disclose company ties in COVID-19 clinical trial paper". Retraction Watch. 4 May 2021. Retrieved 4 May 2021.
17. ^ 习近平签署主席令 授予钟南山等4人国家勋章、国家荣誉称号. Ifeng (in Chinese (China)). 11 August 2020.
18. ^ Wang, Shuo (王硕) (1 June 2016). 政解|中国工程院光华"成就奖"为何两度空缺？. Ifeng News (in Chinese (China)).
19. ^ a b c d e f g h i j k l m Curriculum Vitae of Nan-Shan ZHONG (PDF). 澳門科技大學. 2013 [2020-02-09].
20. ^ Summerskill, W. (2009). Paper of the year 2008: results. The Lancet, 373(9660), 283–284.
21. ^ Zheng JP, Kang J, Huang SG, et al. Effect of carbocisteine on acute exacerbation of chronic obstructive pulmonary disease (PEACE Study): a randomised placebo-controlled study. Lancet 2008; 371: 2013–18.
22. ^ Honorary Editors-in-Chief: Nanshan Zhong, MD. Annals of Translational Medicine. [2020-02-09].
23. ^ 鍾雪冰 (23 March 2007). 鍾南山膺愛丁堡大學榮譽博士. 香港文匯報 (in Chinese (Hong Kong)). Retrieved 9 February 2020.
24. ^ 梁元生 (2013). 第73屆大會 (2013) 鍾南山院士榮譽理學博士 (in Chinese (Hong Kong)). Chinese University of Hong Kong. Retrieved 9 February 2020.
25. ^ 钟南山的妻子是女篮５号. Sina (in Chinese (China)). 16 June 2003. Archived from the original on 16 September 2019. Retrieved 13 February 2019.
26. ^ 钟南山曾是400米栏全国纪录保持者 娶女篮名将为妻. Sina (in Chinese (China)). 22 January 2020. Archived from the original on 22 January 2020. Retrieved 22 January 2020.

## External links[edit]

Scholia has an author profile for Zhong Nanshan.

* Media related to Zhong Nanshan at Wikimedia Commons

Academic offices

Previous:
Zhang Wenkang |  President of Chinese Medical Association
2005-2010  | Next:
Chen Zhu

* v
* t
* e

Severe acute respiratory syndrome (SARS)

* SARS-CoV-1
* SARSr-CoV

General topics|

* 2002–2004 SARS outbreak
* Outbreak among healthcare workers
* List of medical professionals who died
* Air China Flight 112
* SARS conspiracy theory

People|

* Zhong Nanshan
* Ab Osterhaus
* Joanna Tse
* Carlo Urbani
* Jiang Yanyong

In popular culture|

* Plague City: SARS in Toronto
* Molson Canadian Rocks for Toronto
* 1:99 Concert
* Contagion
* SARS Wars

Related articles|

* Coronavirus
* Global alert
* Health in China
* MERS
* MERS-CoV
* COVID-19
* SARS-CoV-2
* pandemic

* v
* t
* e

COVID-19 pandemic

* COVID-19 (disease)
* SARS-CoV-2 (virus)

Timeline

| Pre-pandemic|

* Severe acute respiratory syndrome (SARS)
* Middle East respiratory syndrome (MERS)
* Crimson Contagion
* Disease X
* Event 201
* Exercise Cygnus
* 2019

|

2020|

* January
* responses
* February
* responses
* March
* responses
* April
* responses
* May
* responses
* June
* responses
* July
* responses
* August
* responses
* September
* responses
* October
* responses
* November
* responses
* December
* responses

2021|

* January
* responses
* February
* responses
* March
* responses
* April
* responses
* May
* responses
* June
* responses
* July
* responses
* August
* responses
* September
* responses
* October
* responses
* November
* responses
* December
* responses

2022|

* January
* responses
* February
* responses
* March
* responses
* April
* responses
* May
* responses
* June
* responses
* July
* responses
* August
* responses
* September
* responses
* October
* responses
* November
* December

2023 and after|

* 2023
* 2024

Locations

| Africa

*     * timeline
* national
responses

| Northern|

* Algeria
* Canary Islands
* Ceuta
* Egypt
* Libya
* Mauritania
* Melilla
* Morocco
* Sudan
* Tunisia
* Western Sahara
* Sahrawi Arab Democratic Republic

|

Eastern|

* Burundi
* Comoros
* Djibouti
* Eritrea
* Ethiopia
* Kenya
* Madagascar
* Mauritius
* Mayotte
* Réunion
* Rwanda
* Seychelles
* Somalia
* Puntland
* Somaliland
* South Sudan
* Tanzania
* Uganda

Southern|

* Angola
* Botswana
* Eswatini
* Lesotho
* Malawi
* Mozambique
* Namibia
* South Africa
* list of deaths
* Zambia
* Zimbabwe

Central|

* Cameroon
* Central African Republic
* Chad
* Democratic Republic of the Congo
* Republic of the Congo
* Gabon
* São Tomé and Príncipe

Western|

* Benin
* Burkina Faso
* Cape Verde
* Equatorial Guinea
* Gambia
* Ghana
* timeline
* 2020
* March–July
* August–December
* 2021
* government response
* impact
* education
* Guinea
* Guinea-Bissau
* Ivory Coast
* Liberia
* Mali
* Niger
* Nigeria
* government response
* Saint Helena, Ascension and Tristan da Cunha
* Senegal
* Sierra Leone
* Togo

Asia|

| Central/North|

* Kazakhstan
* Kyrgyzstan
* Russia
* timeline
* January–June
* July–December
* impact
* economic
* social
* political
* Tajikistan
* Turkmenistan
* Uzbekistan

|

East|

* Hong Kong
* Japan
* timeline
* Tokyo
* 2020 Summer Olympics and Paralympics
* North Korea
* South Korea
* Macau
* Mongolia
* Taiwan
* respirator diplomacy

Mainland China|

* lockdown
* detail
* statistics
* vaccination
* Beijing
* 2022 Winter Olympics and Paralympics
* Heilongjiang
* Henan
* Hubei
* Inner Mongolia
* Liaoning
* Shanghai
* 2022 outbreak
* Sichuan
* Tibet
* Xinjiang

South|

* Afghanistan
* Bangladesh
* timeline
* Bhutan
* Maldives
* Nepal
* Pakistan
* Tablighi Jamaat hotspot
* Sri Lanka

India|

* economic impact
* evacuations
* lockdown
* migrant workers' crisis
* statistics
* timeline
* 2020
* January–May
* June–December
* 2021
* union government response
* PM CARES Fund
* SAARC COVID-19 Emergency Fund
* state government responses
* vaccination
* Vaccine Maitri

By location|

* Andaman and Nicobar Islands
* Andhra Pradesh
* Arunachal Pradesh
* Assam
* Bihar
* Chandigarh
* Chhattisgarh
* Dadra and Nagar Haveli and Daman and Diu
* Delhi
* Tablighi Jamaat hotspot
* Goa
* Gujarat
* Haryana
* Himachal Pradesh
* Jammu and Kashmir
* Jharkhand
* Karnataka
* Kerala
* timeline
* Ladakh
* Lakshadweep
* Madhya Pradesh
* Maharashtra
* Manipur
* Meghalaya
* Mizoram
* Nagaland
* Odisha
* Puducherry
* Punjab
* Rajasthan
* Sikkim
* Tamil Nadu
* Telangana
* Tripura
* Uttar Pradesh
* Uttarakhand
* West Bengal

Southeast|

* Brunei
* Cambodia
* East Timor
* Indonesia
* timeline
* 2021
* social restrictions
* Community Activities Restrictions Enforcement
* Laos
* Myanmar
* Singapore
* timeline
* 2020
* 2021
* 2022
* circuit breaker response
* vaccination
* statistics
* Thailand
* timeline
* vaccination
* statistics
* Vietnam
* timeline
* government response

Malaysia|

* impact
* social
* economic
* political
* Aid and relief efforts
* movement control order
* Tablighi Jamaat COVID-19 hotspot
* timeline
* 2020
* 2021
* 2022
* 2023
* statistics
* Johor
* Kuala Lumpur
* Sabah
* Sarawak
* Selangor

Philippines|

* timeline
* 2020
* 2021
* 2022
* government response
* community quarantines
* Luzon
* evacuations
* testing controversy
* vaccination
* Bangsamoro
* Bicol Region
* Cagayan Valley
* Calabarzon
* Caraga
* Central Luzon
* Central Visayas
* Cordillera
* Davao Region
* Eastern Visayas
* Ilocos Region
* Metro Manila
* Mimaropa
* Northern Mindanao
* Soccsksargen
* Western Visayas
* Zamboanga Peninsula
* Overseas Filipinos

West|

* Armenia
* Azerbaijan
* Artsakh
* Bahrain
* Cyprus
* Northern Cyprus
* Egypt
* Georgia
* Abkhazia
* South Ossetia
* Iran
* Iraq
* Kurdistan Region
* Israel
* Jordan
* Kuwait
* Lebanon
* Oman
* Palestine
* Qatar
* Saudi Arabia
* vaccination
* Syria
* Turkey
* timeline
* United Arab Emirates
* Yemen

Europe|

| United Kingdom|

* history
* timeline
* January–June 2020
* July–December 2020
* January–June 2021
* July–December 2021
* January–June 2022
* July–December 2022
* 2023
* responses
* government response
* response
* Operation Rescript
* contracts
* impact
* social
* economic
* education

By location|

* England
* timeline
* 2020
* January–June
* July–December
* 2021
* 2022
* London
* local lockdown regulations
* first tier regulations
* Northern Ireland
* timeline
* 2020
* 2021
* 2022
* Scotland
* timeline
* 2020
* 2021
* 2022
* Wales
* timeline
* 2020
* 2021
* 2022
* Crown Dependencies
* Isle of Man
* Jersey
* Guernsey
* Overseas territories
* Akrotiri and Dhekelia
* British Indian Ocean Territory
* Gibraltar

Eastern|

* Belarus
* timeline
* 2020
* 2021
* 2022
* Kazakhstan
* Moldova
* Gagauzia
* Transnistria
* Russia
* timeline
* January–June 2020
* July–December 2020
* government responses
* political impact
* Turkey
* timeline
* Ukraine
* Crimea
* Sevastopol

Western Balkans|

* Albania
* Bosnia and Herzegovina
* Kosovo
* Montenegro
* North Macedonia
* Serbia
* statistics

European Union|

* Austria
* Belgium
* Bulgaria
* Croatia
* timeline
* Cyprus
* Northern Cyprus
* Czech Republic
* Denmark
* Faroe Islands
* Estonia
* Finland
* Åland
* France
* Guadeloupe
* French Guiana
* Réunion
* Martinique
* Mayotte
* Normandy
* Saint Martin
* Germany
* North Rhine-Westphalia
* government response
* Greece
* Hungary
* Ireland
* timeline
* 2020
* 2021
* 2022
* economic impact
* social impact
* vaccination
* Italy
* lockdowns
* timeline
* Latvia
* Lithuania
* Luxembourg
* Malta
* Netherlands
* government response
* Poland
* Portugal
* Romania
* timeline
* Slovakia
* Slovenia
* Spain
* timeline
* Asturias
* Canary Islands
* Ceuta
* Community of Madrid
* Melilla
* Sweden
* government response
* Operation Gloria

EFTA countries|

* Iceland
* Liechtenstein
* Norway
* Svalbard
* Switzerland

Microstates|

* Andorra
* Monaco
* San Marino
* Vatican City

North
America|

| Atlantic|

* Bermuda
* Greenland
* Saint Pierre and Miquelon

|

Canada|

* timeline
* economic impact
* federal aid
* vaccination
* by province
* military response
* Atlantic Bubble
* Alberta
* timeline
* British Columbia
* Manitoba
* New Brunswick
* Newfoundland and Labrador
* Northwest Territories
* Nova Scotia
* Nunavut
* Ontario
* timeline
* 2020
* 2021
* 2022
* Ottawa
* Peel Region
* Toronto
* York Region
* Provincial government response
* Vaccination
* Prince Edward Island
* Quebec
* Montreal
* boroughs
* Saskatchewan
* timeline
* Yukon

Caribbean|

| Countries|

* Antigua and Barbuda
* Bahamas
* Barbados
* Cuba
* Guantanamo Bay Naval Base
* Dominica
* Dominican Republic
* Grenada
* Haiti
* Jamaica
* Saint Kitts and Nevis
* Saint Lucia
* Saint Vincent and the Grenadines
* Trinidad and Tobago
* timeline

|

British Overseas Territories|

* Anguilla
* British Virgin Islands
* Cayman Islands
* Montserrat
* Turks and Caicos Islands
* response

* Aruba
* Curaçao
* Sint Maarten

Caribbean Netherlands|

* Bonaire
* Saba
* Sint Eustatius

French West Indies|

* Guadeloupe
* Martinique
* Saint Barthélemy
* Saint Martin

US insular areas|

* Puerto Rico
* U.S. Virgin Islands

Central America|

* Belize
* Costa Rica
* El Salvador
* Guatemala
* Honduras
* Mexico
* timeline
* vaccination
* Nicaragua
* Panama

United States|

* Trump administration communication
* timeline
* 2020
* 2021
* social impact
* economic impact
* 2021 hospital crisis

responses|

* federal government
* state and local governments
* California government response
* New York government response
* Texas government response
* Eastern States Multi-state Council
* Midwest Governors Regional Pact
* Western States Pact

By location|

* Alabama
* Alaska
* American Samoa
* Arizona
* Navajo Nation
* Arkansas
* California
* timeline
* S.F. Bay Area
* Colorado
* Connecticut
* Delaware
* Florida
* Georgia
* Guam
* Hawaii
* Idaho
* Illinois
* Indiana
* Iowa
* Kansas
* Kentucky
* Louisiana
* Maine
* Maryland
* timeline
* Massachusetts
* timeline
* Boston
* timeline
* Michigan
* Minnesota
* Mississippi
* Missouri
* Montana
* Nebraska
* Nevada
* timeline
* New Hampshire
* New Jersey
* New Mexico
* New York
* New York City
* timeline
* North Carolina
* North Dakota
* Northern Mariana Islands
* Ohio
* Columbus
* Oklahoma
* Oregon
* Portland
* Pennsylvania
* Philadelphia
* Puerto Rico
* Rhode Island
* South Carolina
* South Dakota
* Tennessee
* Texas
* timeline
* Austin
* U.S. Virgin Islands
* Utah
* Vermont
* Virginia
* Washington
* Washington, D.C.
* White House
* West Virginia
* Wisconsin
* Wyoming

Oceania|

* American Samoa
* Cook Islands
* Easter Island
* Federated States of Micronesia
* Fiji
* French Polynesia
* Guam
* Hawaii
* Kiribati
* Marshall Islands
* Nauru
* New Caledonia
* Niue
* Northern Mariana Islands
* Palau
* Papua New Guinea
* Bougainville
* Pitcairn Islands
* Samoa
* Solomon Islands
* Tokelau
* Tonga
* Tuvalu
* Vanuatu
* Wallis and Futuna

Australia|

* timeline
* 2020
* 2021
* January–June
* July–December
* 2022
* Australian Capital Territory
* Christmas Island
* Cocos (Keeling) Islands
* New South Wales
* Norfolk Island
* Northern Territory
* Queensland
* South Australia
* Tasmania
* Victoria
* Western Australia

New Zealand|

* timeline
* 2020
* 2021
* 2022
* 2023
* economic impact
* government response
* Alert levels
* Traffic light system
* social impact
* managed isolation

South
America|

* Argentina
* statistics
* human rights
* Bolivia
* Brazil
* São Paulo
* Chile
* statistics
* Easter Island
* Colombia
* timeline
* Ecuador
* Falkland Islands
* French Guiana
* Guyana
* Paraguay
* Peru
* statistics
* Cusco
* Suriname
* Uruguay
* Venezuela

Others|

* Antarctica
* Cruise ships
* Diamond Princess
* Grand Princess
* Naval ships
* Charles de Gaulle
* USS Theodore Roosevelt

Impact

| Culture and
entertainment|

| Arts and
cultural heritage|

* References in popular culture
* Cinema
* films affected
* Corona-chan
* Disney
* Fashion industry
* Music industry
* Performing arts
* Television
* U.S.
* U.S. sports
* programs affected
* Video games

|

Education|

* Female education
* Homeschooling

By country|

* Ghana
* Ireland
* United Kingdom
* exam grading controversy
* United States

Sports|

* Bio-secure bubble

By country|

* Ireland
* Philippines

By sport|

* Association football
* Baseball
* Basketball
* NBA
* Combat sports
* Cricket
* Disc golf
* Gaelic games
* Gridirion football (NCAAF, NFL, and CFL)
* Ice hockey
* Motorsport
* Rugby league

Society
and rights|

| Social impact|

* Social media
* Stigma
* COVID-19 parties
* Children
* foster care in the U.S.

|

Labor|

* Healthcare workers
* Indian migrant workers
* Great Resignation
* Strikes

Human rights|

* Argentina
* Hong Kong
* Myanmar
* North Korea
* Turkmenistan

Legal|

* Abortion in the U.S.
* Crime
* Domestic violence
* Prisons
* U.S. immigration detention

Minority|

* Gender
* LGBT community
* African communities
* Disability community
* Native American communities
* Xenophobia and racism

Religion|

* Catholic Church
* Hajj

Economic|

* Charitable activity
* COVID-19 scams
* Travel restrictions

By country|

* Canada
* India
* Ireland
* COVID-19 Pandemic Unemployment Payment
* Malaysia
* New Zealand
* Russia
* U.K.
* U.S.

By industry|

* Aviation
* Airlines
* Cannabis industry
* Food industry
* meat industry in Canada
* meat industry in the U.S.
* restaurant industry in the U.S.
* Hospitals
* ICU capacity
* Long-term care facilities
* Mink farming
* Public transport
* Retail
* Tourism

Supply and trade|

* Shortages
* Chip supply
* Energy
* Global supply chain
* Oil price war
* Food security

Financial markets|

* Global stock market crash
* COVID-19 recession
* Inflation

Information|

* Journalism
* Media coverage
* Wikipedia's response

Misinformation|

* Governments
* China
* United States
* By country
* Canada
* Philippines
* Ivermectin
* Plandemic

Politics|

* National responses
* Legislation
* European Union

Political impact|

* Ireland
* Malaysia
* Russia

Protests|

* Canada
* convoy protest
* China
* Italy
* Germany
* Idar-Oberstein shooting
* the Netherlands
* New Zealand
* Serbia
* United Kingdom
* United States
* Open the States

International relations|

* Aid
* Italy
* Moldovan–Romanian collaboration
* Nicaragua–Taiwan relations
* Respirator diplomacy of Taiwan
* Vaccine diplomacy

Language|

* Anthropause
* Doomscrolling
* Flattening the curve
* Green recovery
* Long COVID
* Quarantini
* Social distancing
* Superspreader
* Twindemic
* Zero-COVID
* Zoom
* Zoom towns

Others|

* Animals
* Cluster 5
* Environment
* Military
* Pregnant women
* Science and technology

Health issues

| Medical topics|

* Transmission
* Symptoms
* Cancer
* Endemic COVID-19
* Skin manifestations
* Long COVID
* Mental health
* neurological, psychological and other mental health outcomes
* Pregnancy
* Non-COVID-19–related health issues
* Shortages
* Raise the line
* Rehabilitation
* Unproven medical methods

|

Testing and
epidemiology|

* Datasets
* Death rates by country
* Disease testing
* Breathalyzer
* Operation Moonshot
* Test to Release
* UK Rapid Test Consortium
* AbC-19 rapid antibody test
* investigations into the origins
* lab leak theory
* Rapid antigen test
* Software
* Surveillance
* Undercounting COVID-19 deaths

Apps|

* Aarogya Setu
* BlueTrace
* careFIJI
* Coronavirus Australia
* Corona-Warn-App
* COVID-19 Contact-Confirming Application
* COVID Alert (Canada)
* COVID AlertSA (South Africa)
* COVIDSafe
* COVID Tracker Ireland
* Covid Watch
* Decentralized Privacy-Preserving Proximity Tracing
* Exposure Notification
* Health Code
* Healthy Together
* Immuni
* Koronavilkku
* LeaveHomeSafe
* MySejahtera
* NHS COVID-19
* NZ COVID Tracer
* NZ Pass Verifier
* PathCheck
* PeduliLindungi
* SafeEntry
* SafePass
* StaySafe.ph
* SwissCovid
* TCN Protocol
* Test, Trace, Protect
* Thai Chana
* TousAntiCovid
* TraceTogether
* Valtrace
* Zoe Health Study

Prevention|

* Air purifier (Corsi–Rosenthal Box)
* Chloroquine and hydroxychloroquine
* COVID fatigue
* Evacuations
* Face masks
* Anti-mask sentiment
* United States
* Flattening the curve
* Great Barrington Declaration
* International aid
* Lockdowns
* Public health mitigation
* Safe Hands Challenge
* Social distancing
* Workplace hazard controls
* Zero-COVID

Vaccines|

| Topics|

* Authorizations
* Clinical research
* Deployment
* Development
* EU Certificate
* Misinformation and hesitancy
* Deaths of anti-vaccine advocates
* US
* Operation Warp Speed (U.S.)
* Post-vaccination complications
* Vaccine card
* Vaccine passports

|

Authorized|

| DNA|

* ZyCoV-D

|

Inactivated|

* Chinese Academy of Medical Sciences
* CoronaVac
* Covaxin
* COVIran Barekat
* CoviVac (Russia)
* FAKHRAVAC
* Minhai
* QazCovid-in
* Sinopharm BIBP
* Sinopharm WIBP
* Turkovac
* Valneva

mRNA|

* Moderna
* Pfizer–BioNTech

Subunit|

* Abdala
* Corbevax (Bio E COVID-19)
* COVAX-19
* EpiVacCorona
* IndoVac
* MVC
* Noora
* Novavax
* Razi Cov Pars
* Sinopharm CNBG
* Soberana 02
* Soberana Plus
* ZF2001 (Zifivax)

Viral vector|

* Convidecia
* Janssen
* Oxford–AstraZeneca
* Sputnik V
* Sputnik Light

Virus-like particles|

* CoVLP

In trials|

| Attenuated|

* COVI-VAC (United States)

|

DNA|

* AG0302-COVID‑19
* GX-19
* Inovio

Inactivated|

* KD-414
* NDV-HXP-S

RNA|

* ARCT-021
* ARCT-154
* Bangavax
* CureVac (terminated)
* HGC019
* mRNA-1283
* PTX-COVID19-B
* Sanofi–Translate Bio (terminated)
* Stemirna COVID-19 vaccine
* Walvax

Subunit|

* 202-CoV
* AKS-452
* EuCorVac-19
* IVX-411
* Nanocovax
* ReCOV
* Sanofi–GSK
* S-268019
* SCB-2019
* SCTV01C
* Skycovione
* UB-612
* V-01
* V451 (terminated)
* Vabiotech
* West China Hospital
* Zhongyianke Biotech–Liaoning Maokangyuan Biotech

Viral vector|

* AdCLD-CoV19
* BriLife
* COH04S1
* DelNS1-2019-nCoV-RBD-OPT
* GRAd-COV2
* ImmunityBio
* iNCOVACC
* INNA-051
* NDV-HXP-S
* Vaxart COVID-19 vaccine

Virus-like particles|

* ABNCoV2
* LYB001
* MigVax-101
* VBI-2902

Deployment
by location|

| Africa|

* Algeria
* Angola
* Benin
* Botswana
* Burkina Faso
* Burundi
* Cameroon
* Cape Verde
* Cameroon
* Chad
* Comoros
* Democratic Republic of the Congo
* Djibouti
* Egypt
* Equatorial Guinea
* Eswatini
* Ghana
* Morocco
* Nigeria
* Senegal
* South Africa
* Zimbabwe

|

Asia|

* Bangladesh
* Bhutan
* Mainland China
* India
* Indonesia
* Iran
* Israel
* Japan
* Kazakhstan
* Malaysia
* Nepal
* Philippines
* Russia
* Singapore
* South Korea
* Sri Lanka
* Taiwan
* Thailand
* Turkey
* United Arab Emirates
* Vietnam

Europe|

* Albania
* Bosnia and Herzegovina
* Bulgaria
* Croatia
* Denmark
* France
* Germany
* Greece
* Hungary
* Iceland
* Ireland
* Italy
* Moldova
* Norway
* Portugal
* Romania
* Russia
* Spain
* Sweden
* Switzerland
* Ukraine
* United Kingdom

North America|

* Canada
* Ontario
* Quebec
* Cuba
* Haiti
* Mexico
* United States
* mandates

Oceania|

* Australia
* Fiji
* New Zealand

South America|

* Argentina
* Brazil
* Colombia
* Peru

Others|

* Antarctica

Treatment|

* Drug development
* Drug repurposing research
* Baricitinib
* Dexamethasone
* Extracorporeal membrane oxygenation
* Open-source ventilator
* PANORAMIC trial (UK)
* RECOVERY Trial (UK)
* Solidarity trial (WHO)

Monoclonal antibodies|

* Bamlanivimab/etesevimab
* Bamlanivimab
* Etesevimab
* Bebtelovimab
* Casirivimab/imdevimab
* Regdanvimab
* Sarilumab
* Sotrovimab
* Tixagevimab/cilgavimab
* Tocilizumab

Small molecule antivirals|

* Broad-spectrum
* Ensitrelvir
* Molnupiravir
* Remdesivir
* Co-packaged
* Nirmatrelvir
* ritonavir

Variants

| Specific|

* Alpha
* Beta
* Gamma
* Delta
* Epsilon
* Zeta
* Eta
* Theta
* Iota
* Kappa
* Lambda
* Mu
* Omicron
* timeline

|

General|

* Cluster 5
* Lineage B.1.617
* Lineage B.1.640.2
* Variant of concern

Institutions

| Hospitals and
medical clinics|

| Mainland China|

* Central Hospital of Wuhan
* Dabie Mountain Regional Medical Centre
* Fangcang hospitals
* Huoshenshan Hospital
* Leishenshan Hospital
* Xinjia Express Hotel
* Wuhan Jinyintan Hospital

|

Others|

* Hospital ships
* Garran Surge Centre (Australia)
* Hospital El Salvador
* SevenHills Hospital (India)
* Kemayoran Athletes Village (Indonesia)
* Pyongyang General Hospital (North Korea)
* Malaysia Agro Exposition Park Serdang (Malaysia)
* Mega Ligtas COVID Centers (Philippines)
* Kandakadu Treatment and Rehabilitation Centre (Sri Lanka)
* Sancaktepe Prof. Dr. Feriha Öz Emergency Hospital (Turkey)
* Yeşilköy Prof. Dr. Murat Dilmener Emergency Hospital (Turkey)
* COVID-19 hospitals in the United Kingdom
* NHS Nightingale Hospitals (England)
* Birmingham
* London
* North East
* North West
* Yorkshire and the Humber
* NHS Louisa Jordan (Scotland)
* Dragon's Heart Hospital (Wales)

Organizations|

| Global|

|

By location|

* National Cabinet (Australia)
* ScienceUpFirst (Canada)
* Wuhan Institute of Virology (China)
* Independent SAGE (United Kingdom)

Health
institutes|

* Africa Centres for Disease Control and Prevention (African Union)
* Ghana Infectious Disease Centre (Ghana)
* Department of Health (Hong Kong)
* Korea Disease Control and Prevention Agency (South Korea)
* National Institute for Communicable Diseases (South Africa)
* Taiwan Centers for Disease Control (Taiwan)

Pandemic
institutes|

* National COVID-19 Commission Advisory Board (Australia)
* COVID-19 Immunity Task Force (Canada)
* COVID-19 Supply Council (Canada)
* PREPARE (European Union)
* National Expert Group on Vaccine Administration for COVID-19 (India)
* COVID-19 Response Acceleration Task Force (Indonesia)
* National Public Health Emergency Team (Ireland)
* Novel Coronavirus Expert Meeting (Japan)
* Crisis Preparedness and Response Centre (Malaysia)
* Defeat COVID-19 Ad Hoc Committee (Philippines)
* Inter-Agency Task Force for the Management of Emerging Infectious Diseases (Philippines)
* Central Epidemic Command Center (Taiwan)
* Coronavirus Scientific Advisory Board (Turkey)
* COVID-19 Genomics UK Consortium (United Kingdom)
* Imperial College COVID-19 Response Team (United Kingdom)
* Joint Biosecurity Centre (United Kingdom)
* Vaccine Taskforce (United Kingdom)
* COVID-19 Advisory Board (United States)
* Great American Economic Revival Industry Groups (United States)
* White House Coronavirus Task Force (United States)
* White House COVID-19 Response Team (United States)
* GACH (Uruguay)

Relief funds|

* PM CARES Fund (India)
* SAARC COVID-19 Emergency Fund (India)
* Artist Relief (United States)

People

| Medical
professionals|

* Ai Fen
* Corona Rintawan
* Li Wenliang
* Liu Wen
* Xie Linka
* Zhang Wenhong

|

Researchers|

* Awang Bulgiba Awang Mahmud
* Roberto Burioni
* Chen Wei
* Kizzmekia Corbett
* Andrea Crisanti
* Peter Daszak
* Christian Drosten
* Neil Ferguson
* Dale Fisher
* George F. Gao
* Azra Ghani
* Sarah Gilbert
* Guan Yi
* Kentaro Iwata
* Katalin Karikó
* Matt Keeling
* Trudie Lang
* Li Lanjuan
* W. Ian Lipkin
* Ma Xiaowei
* Shabir Madhi
* Allison McGeer
* Camilla Rothe
* Shi Zhengli
* Moncef Slaoui
* Mike Tildesley
* John Todd
* Wang Chen
* Wang Guangfa
* Drew Weissman
* Yuen Kwok-yung
* Zeng Guang
* Zhang Jixian
* Zhang Yongzhen
* Zhong Nanshan

Officials|

| WHO|

* Tedros Adhanom
(Director-General of the WHO)
* Bruce Aylward
(Team lead of WHO-China COVID-19 mission)
* Maria Van Kerkhove
(Technical Lead for COVID-19 response)
* Michael J. Ryan
(Executive Director of the WHO Health Emergencies Programme)

|

By location|

* Frank Atherton
(Wales)
* Ashley Bloomfield
(New Zealand)
* Catherine Calderwood
(Scotland)
* Chang Shan-chwen
(Taiwan)
* Anutin Charnvirakul
(Thailand)
* Chen Shih-chung
(Taiwan)
* Kenneth Chuang Yin-ching
(Taiwan)
* Victor Costache
(Romania)
* Fabrizio Curcio
(Italy)
* Carmen Deseda
(Puerto Rico)
* Jaap van Dissel
(the Netherlands)
* Christian Drosten
(Germany)
* Francisco Duque III
(Philippines)
* Anthony Fauci
(United States)
* Francesco Paolo Figliuolo
(Italy)
* Graça Freitas
(Portugal)
* Henrique Gouveia e Melo
(Portugal)
* Matt Hancock
(United Kingdom)
* Hamad Hasan
(Lebanon)
* Greg Hunt
(Australia)
* Tony Holohan
(Ireland)
* Jeong Eun-kyeong
(South Korea)
* Fahrettin Koca
(Turkey)
* Li Keqiang
(China)
* Hugo López-Gatell Ramírez
(Mexico)
* Michael McBride
(Northern Ireland)
* Oriol Mitjà
(Andorra)
* Zweli Mkhize
(South Africa)
* Doni Monardo
(Indonesia)
* Alma Möller
(Iceland)
* Saeed Namaki
(Iran)
* Ala Nemerenco
(Moldova)
* Nguyễn Thanh Long
(Vietnam)
* Noor Hisham Abdullah
(Malaysia)
* Ali Pilli
(Northern Cyprus)
* Daniel Salinas
(Uruguay)
* Jérôme Salomon
(France)
* Fernando Simón
(Spain)
* Gregor Smith
(Scotland)
* Su Ih-jen
(Taiwan)
* Łukasz Szumowski
(Poland)
* Theresa Tam
(Canada)
* Anders Tegnell
(Sweden)
* Þórólfur Guðnason
(Iceland)
* Sotiris Tsiodras
(Greece)
* Harsh Vardhan
(India)
* Víðir Reynisson
(Iceland)
* Carla Vizzotti
(Argentina)
* Vlad Voiculescu
(Romania)
* Chris Whitty
(United Kingdom)
* Lawrence Wong
(Singapore)
* Jeff Zients
(United States)

Others|

* Chen Qiushi
* Brett Crozier
* Fang Bin
* Fang Fang
* Joseph Ashitey Hammond
* Li Zehua
* Captain Tom Moore
* Qiu Menghuang
* Ren Zhiqiang

Deaths|

* List

Data (templates)

| Global|

* Cases, deaths, recoveries by country
* Tests, cases, tests per capita, cases per capita by country
* Tests, cases, tests per capita, cases per capita by country subdivision
* WHO situation reports
* cases
* January 2020
* February 2020
* March 2020
* April 2020
* May 2020
* June 2020
* July 2020
* August 2020
* September 2020
* October 2020
* November 2020
* December 2020
* January 2021
* February 2021
* March 2021
* April 2021
* May 2021
* June 2021
* July 2021
* August 2021
* deaths
* World map by countries: confirmed per capita
* China
* Hospital beds by country
* Lockdowns

|

Africa|

* Algeria
* Angola
* Benin
* Botswana
* Burkina Faso
* Burundi
* Cameroon
* Comoros
* Egypt
* Eswatini
* Ethiopia
* Ghana
* cases chart
* Ivory Coast
* Kenya
* Libya
* Malawi
* Mali
* Mauritania
* Mauritius
* Morocco (including occupied Western Sahara)
* Mozambique
* Namibia
* Nigera
* cases chart
* São Tomé and Príncipe
* Senegal
* Seychelles
* Sierra Leone
* South Africa
* cases chart
* South Sudan
* Sudan
* Tanzania
* Togo
* Tunisia
* Uganda
* Zambia
* Zimbabwe
* cases chart

Americas|

* Argentina
* Bolivia
* Brazil
* Canada
* by province
* vaccinations by province
* Chile
* by commune
* Colombia
* Costa Rica
* cases chart
* Cuba
* Dominican Republic
* Ecuador
* El Salvador
* Guatemala
* Haiti
* Honduras
* Mexico
* cases chart
* Nicaragua
* Panama
* Paraguay
* Peru
* United States
* by state
* Uruguay
* Venezuela

Asia|

* Afghanistan
* Armenia
* Artsakh
* Azerbaijan
* Bahrain
* Bangladesh
* by division
* Bhutan
* cases chart
* Brunei
* Cambodia
* cases chart
* summary
* China
* cases chart
* confirmed per capita
* lockdowns
* by province
* Hong Kong
* Macau
* Cyprus
* East Timor
* Egypt
* Georgia
* India
* Indonesia
* cases chart
* Iran
* cases chart
* Iraq
* Israel
* cases chart
* Japan
* cases chart
* Jordan
* Kazakhstan
* Kuwait
* cases chart
* Kyrgyzstan
* Laos
* Lebanon
* Malaysia
* cases chart
* charts
* Myanmar
* cases chart
* summary
* Nepal
* cases chart
* Oman
* cases chart
* Pakistan
* cases chart
* Philippines
* cases chart
* areas of quarantine
* vaccinations chart
* Qatar
* Russia
* cases chart
* by federal subject
* North Asia
* Saudi Arabia
* Singapore
* South Korea
* cases chart
* vaccinations charts
* Sri Lanka
* Syria
* Taiwan
* vaccination charts
* Tajikistan
* Thailand
* cases chart
* Turkey
* cases chart
* United Arab Emirates
* cases chart
* Uzbekistan
* cases chart
* Vietnam
* statistics charts
* Yemen

Europe|

* Albania
* Austria
* cases chart
* Belarus
* Belgium
* cases chart
* Bosnia and Herzegovina
* Bulgaria
* cases chart
* Croatia
* Cyprus
* Czech Republic
* Denmark
* cases chart
* Faroe Islands
* Estonia
* cases chart
* Finland
* France
* cases chart
* Germany
* cases chart
* Greece
* Hungary
* Iceland
* cases chart
* Ireland
* cases chart
* Italy
* cases chart
* statistics charts
* vaccinations chart
* Kosovo
* Latvia
* cases chart
* Lithuania
* cases chart
* Luxembourg
* Malta
* Moldova
* Monaco
* Montenegro
* Netherlands
* North Macedonia
* Norway
* cases chart
* Poland
* cases chart
* by voivodeship
* Portugal
* cases chart
* Romania
* cases chart
* Russia
* cases chart
* by federal subject
* North Asia
* San Marino
* Serbia
* Slovakia
* cases chart
* by region
* Slovenia
* cases chart
* Spain
* cases chart
* Sweden
* cases chart
* Switzerland
* cases chart
* Turkey
* cases chart
* Ukraine
* United Kingdom
* Scotland
* 2020
* 2021
* Gibraltar
* vaccinations chart
* daily
* by nation
* Vatican City

Oceania|

* Australia
* by state/territory
* Fiji
* French Polynesia
* New Caledonia
* New Zealand
* Papua New Guinea
* Solomon Islands

Others|

* Cruise ships
* Diamond Princess

Authority control databases

International|

* FAST
* ISNI
* VIAF

National|

* United States
* Australia

Academics|

* ORCID

*[m.]: married
*[v]: View this template
*[t]: Discuss this template
*[e]: Edit this template